enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Peptide therapeutics - Wikipedia

    en.wikipedia.org/wiki/Peptide_therapeutics

    Peptide therapeutics are peptides or polypeptides (oligomers or short polymers of amino acids) which are used to for the treatment of diseases. Naturally occurring peptides may serve as hormones , growth factors , neurotransmitters , ion channel ligands , and anti-infectives ; peptide therapeutics mimic such functions.

  3. Is AstraZeneca a Buy as It Eyes the Weight Loss Market? - AOL

    www.aol.com/finance/astrazeneca-buy-eyes-weight...

    AstraZeneca's AZD5004 is a particularly interesting development because it's an oral glucagon-like peptide-1 (GLP-1) medication-- a major differentiation from the current mainstream solutions.

  4. 5 Peptides That May Help With Weight Loss, According to ... - AOL

    www.aol.com/5-peptides-may-help-weight-181100871...

    In order to use peptides that are FDA-approved for weight loss, you need a prescription. There are also some specifics for each drug to indicate if you would be a good candidate.

  5. US FDA warns online vendors selling unapproved weight ... - AOL

    www.aol.com/news/us-fda-warns-online-vendors...

    The letters were issued to Xcel Peptides, Swisschems, Summit Research and Prime Peptides last week after the U.S. health regulator conducted a review of their respective websites in October. The ...

  6. Sarepta Therapeutics - Wikipedia

    en.wikipedia.org/wiki/Sarepta_Therapeutics

    Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States.. Incorporated in 1980 as AntiVirals, [2] shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta ...

  7. Peptide Therapeutics Market to Witness 5.94% CAGR by 2031 ...

    lite.aol.com/tech/story/0022/20240927/9237572.htm

    The peptide therapeutics market was dominated by North America in 2021. The rise of the regional market is primarily due to the expansion of the biotechnology industry, growing diagnostics for cancer and other diseases, and growing consumer awareness of peptide therapeutic products.

  8. Bi-specific T-cell engager - Wikipedia

    en.wikipedia.org/wiki/Bi-specific_T-cell_engager

    After clinical trials, in January 2022, the US FDA approved tebentafusp (a BiTE targeting the gp100 peptide) for HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma. [20]

  9. Has Sarepta Therapeutics Become a No-Brainer Stock Buy ... - AOL

    www.aol.com/sarepta-therapeutics-become-no-b...

    Sarepta Therapeutics (NASDAQ: SRPT) stock has been flying of late, as the company got some great news from the FDA that has the potential to be a game changer for its business. Investors are ...